Trauma

Disease

Related News

Psychedelic Therapies Show Promise for Depression, Anxiety and Addiction

Clinical trials show psychedelic substances like psilocybin, LSD and MDMA combined with therapy can effectively treat depression, anxiety and addiction. Several substances are in Phase III trials, with esketamine already approved for treatment-resistant depression. Research suggests these treatments may work with fewer doses than traditional medications.

Related Clinical Trials

NCT ID Title Status Phase
NCT07760701

Description of the Lived Experiences of Family Caregivers for People With Mental Health Comorbidities

COMPLETED
NCT07691931

TBE Zone 0/1 PMS in Japan

NOT_YET_RECRUITING
NCT07677449

Preventing Harmful Alcohol Use Among Trauma Patients in Cameroon

NOT_YET_RECRUITING NA
NCT07644793

Litter Packaging in the Lateral Position: Effects of Position and Vacuum Mattress Packaging on Pulmonary Function

NOT_YET_RECRUITING NA
NCT07634185

Clinical Evaluation of an AI Risk Prediction System (AI-TRiPS)

NOT_YET_RECRUITING EARLY_PHASE1
NCT07589777

Trauma-Informed Yoga Intervention in Young Women

NOT_YET_RECRUITING NA
NCT07585916

Prenatal Yoga Intervention in Pregnant Women

RECRUITING NA
NCT07581327

Data-Driven Lay First Responder Program in Cameroon

NOT_YET_RECRUITING NA
NCT07536854

Early Delirium Prediction Via Serial EEG Trajectories and Machine Learning

COMPLETED
NCT07492758

Management of Extremity Injuries Registry

COMPLETED